Colistimethate Sodium Inhaled, IV

Permitted Indications

Colistimethate sodium inhalation powder (Colobreathe®)

Only on the advice of a Cystic Fibrosis Specialist prior to continuation in Primary Care for:

  1. First line use for suppressive therapy of chronic pulmonary infection due to Pseudomonas aeruginosa in adults and children aged 6 years and older with cystic fibrosis.

Colistimethate sodium injection

Only on the advice of a Medical Microbiologist, Infection Specialist or Respiratory Specialist for:

  1. Patients with gram-negative infections resistant to other antibacterials.
  2. As a nebulised solution for suppressive therapy of chronic pulmonary infection due to Pseudomonas aeruginosa in children aged >1 month and adults with cystic fibrosis.

Wards Stocked